Skip to main content Back to Top
Advertisement

12/18/2019

Rabies Immune Globulin

Reason for the Shortage

    • Grifols has HyperRAB S-D available.
    • Kedrion has KEDRAB available.
    • Sanofi Pasteur has Imogam Rabies-HT available.

Available Products

    • HyperRAB solution for injection, Grifols, 300 units/mL, 1 mL vial, NDC 13533-0318-10
    • HyperRAB solution for injection, Grifols, 300 units/mL, 1 mL vial, NDC 13533-0318-01
    • HyperRAB solution for injection, Grifols, 300 units/mL, 5 mL vial, NDC 13533-0318-50
    • HyperRAB solution for injection, Grifols, 300 units/mL, 5 mL vial, NDC 13533-0318-05
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 10 mL vial, NDC 13533-0618-11
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 10 mL vial, NDC 13533-0618-10
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 2 mL vial, NDC 13533-0618-02
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 3 mL vial, NDC 13533-0618-20
    • Imogam Rabies-HT solution for injection, Sanofi Pasteur, 150 units/mL, 10 mL vial, NDC 49281-0190-10
    • Imogam Rabies-HT solution for injection, Sanofi Pasteur, 150 units/mL, 2 mL vial, NDC 49281-0190-20
    • KEDRAB solution for injection, Kedrion Biopharma, Inc., 150 units/mL, 10 mL vial, NDC 76125-0150-10
    • KEDRAB solution for injection, Kedrion Biopharma, Inc., 150 units/mL, 2 mL vial, NDC 76125-0150-02

Updated

Updated December 18, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 11, 2019 by Rachael Freeman, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins